Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide
Authors:
- Robert J. SmithRSRobert J. Smith
- 1 January 2011
- journal article
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 268 (1) , 1-13
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Modelling imperfect adherence to HIV induction therapyBMC Infectious Diseases, 2010
- Estimating the Stoichiometry of Human Immunodeficiency Virus EntryJournal of Virology, 2009
- Global behaviour of an age-infection-structured HIV model with impulsive drug-treatment strategyJournal of Theoretical Biology, 2008
- Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitorJournal of Theoretical Biology, 2008
- Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibodyVirology, 2007
- Optimal drug treatment regimens for HIV depend on adherenceJournal of Theoretical Biology, 2007
- Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: Implications for HIV-1 transmission in humansVirology, 2007
- Electron Tomography of the Contact between T Cells and SIV/HIV-1: Implications for Viral EntryPLOS Pathogens, 2007
- Perspectives on the basic reproductive ratioJournal of The Royal Society Interface, 2005
- Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtideAIDS, 2004